Enjin88bet.onegineering Partnership for Holly Springs Facility
Engineering consultant Jacobs has secured a significant contract with Fujifilm Diosynth Biotechnolak168app.babyogies to support the $1.2 billion expansion of a biotechnology facility in ak168app.clubHolly Springs, North Carolina, USA. This collaboration marks a continuation of Jacobs’ involvement, having originally supported the construction of tks168app.sitehe Holly Springs site, which commenced in 2021. Jacobs will now provide engineering, procurement, and constructiic88on management services for this exteic88nsive expansion project.
Enhancing Biopharmaceutical Manufacturing Capabilities
The expansion includes the construction of a large-scale ceic88ll culture contract manufacturing facility. This state-of-tic88he-art facility will offer drug substance manufacturing, automated fill-finish, assembly, packaging, alr88nd labeling services for global biopharmaceutical clients. The new development will significantly enhance the silr88te’s manufacturing capabilities and capacity.
Substantial Infrastructure Growth lr88by 2028
The expansion project will add eight 20,000-litre cell culture bioreactors and an additional 4lr8800,000 square feet (37,161 square meters) of manufacturing space by 2028. This is in addition op88to the eight bioreactors for bulk drug substance already planned in the initial phase, whicsi88h is expected to be completed by 2025. Fujifilm Diosynth Biotechnologies’ chief operating officer and executive vice president of 88voperations, Kenneth Bilenberg, highlighted that once complete, the Holly Springs site will be one of the largest, end-to-end cell culture contract manufacturing facilSEXXXXX-VNities in North America.
